Press Releases - Supernus Pharmaceuticals

Date	Title
November 26, 2024	Supernus to Participate in the 36th Annual Piper Sandler Healthcare Conference	PDF Version
November 13, 2024	Supernus Pharmaceuticals to Participate in the 2024 Jefferies London Healthcare Conference	PDF Version
November 4, 2024	Supernus Announces Third Quarter 2024 Financial Results	PDF Version
October 31, 2024	Supernus Presents Promising Data from Open-Label Phase 2a Study of SPN-820 Data in Major Depressive Disorder at Psych Congress 2024	PDF Version
October 21, 2024	Supernus Pharmaceuticals to Host Conference Call and Webcast on November 4, 2024 to Discuss Third Quarter 2024 Financial Results	PDF Version
October 17, 2024	Supernus Announces Promising Data from Open-Label Phase 2a Study of SPN-820 in Adults with Major Depressive Disorder	PDF Version
October 10, 2024	Supernus Pharmaceuticals to Host Webcast to Review Open-Label Phase 2a Study of SPN-820 for the Treatment of Major Depressive Disorder	PDF Version
September 24, 2024	Busy Philipps Encourages Women to Take Charge of Their ADHD This Fall in Ongoing Collaboration with Supernus Pharmaceuticals and Qelbree	PDF Version
September 19, 2024	Supernus Pharmaceuticals to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit	PDF Version
August 28, 2024	Supernus Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference	PDF Version